A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen(The Netherlands Cancer Institute), Alfred Zippelius(University of Basel)
Cited by 1,173
Related Papers
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
|Immunity|2018|937
Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin
|The Journal of Immunology|2007|330
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
|Immunity|2023|176
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
|Nature Communications|2023|88